What Does the Retail Landscape of 2025 Look Like?

Designed for retail leaders and lovers alike, Retail Refined explores the in-store technology of the future, challenges the industry’s preconceived notions, and brings together retail’s biggest names to understand the brand strategies that will define the next decade in retail.

 

The past year has been a deeply transformative one for the retail industry, which saw already emerging trends in online shopping, curbside pickup and more accelerated in the face of the COVID-19 pandemic.
Now, even with vaccines continuing to roll out and a true reopening commencing, retail isn’t going backward. In fact, the evolution could be just beginning.

On this episode of MarketScale’s Retail Refined with Melissa Gonzalez, Gonzalez welcomed fashion and design icon Rebecca Minkoff to explore another of her areas of expertise – retail’s digital landscape. In fact, she’s a pioneer with a history of integrating innovative technology, such as “magic mirrors” and self-checkout, into her label’s physical stores.

“Now, the customer is so used to the online experience that, if she doesn’t get that in the store, she’ll be like, ‘Ugh, I’m just going to order online’” -Rebecca Minkoff

That experience makes her uniquely qualified to assess how the retail industry might respond to mounting pressures for more innovation, integration and interaction in the months and years after the pandemic draws to a close.
“Now, the customer is so used to the online experience that, if she doesn’t get that in the store, she’ll be like, ‘Ugh, I’m just going to order online,’” Minkoff said.

It’s those raised expectations that retailers are now competing against, though there are exciting new technologies, data tools and more emerging to help them do it.

Click here to pre-order or to read more Rebecca Minkoff’s new book, Fearless.

To hear more, listen to the entirety of this episode of Retail Refined.

Listen to Previous Episodes of Retail Refined Right Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More